Completed OBSERVATIONAL NCT06366581
Transcriptomic Analysis of Incisional Hernia Based on High-throughput Sequencing Technology
Sponsor: Fudan University
Conditions
Extracellular Matrix Alteration Incisional Hernia
Interventions
Transcriptomic analysis
Updated 3 times since 2024 Last updated: Apr 14, 2024 Started: Mar 1, 2023 Primary completion: Sep 1, 2023 Completion: Mar 1, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT06366581, this observational or N/A phase trial focuses on Extracellular Matrix Alteration and Incisional Hernia and remains completed. Sponsored by Fudan University, it has been updated 3 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
3 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
May 2024 — Jul 2024 [monthly]
Completed
First recorded
Mar 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Fudan University
Data source: Fudan University
For direct contact, visit the study record on ClinicalTrials.gov .